One or two autografts for myeloma?
Open Access
- 1 April 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (7), 3899-3900
- https://doi.org/10.1182/blood-2007-12-127704
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trialBlood, 2008
- High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 yearsBone Marrow Transplantation, 2007
- Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical StudyJournal of Clinical Oncology, 2007
- Long‐term outcome results of the first tandem autotransplant trial for multiple myelomaBritish Journal of Haematology, 2006
- High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMABlood, 2005
- Intensive Versus Double Intensive Therapy in Untreated Multiple Myeloma: Final Analysis of the HOVON 24 Trial.Blood, 2005
- An elective single autograft with high-dose melphalan: single-center study of 451 patientsBone Marrow Transplantation, 2005
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Total Therapy With Tandem Transplants for Newly Diagnosed Multiple MyelomaBlood, 1999
- High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical TrialBlood, 1998